Thalidomide- and Lenalidomide-Associated Thromboembolism Among Patients With Cancer

Authors:
  • CBCharles L. Bennett
    Charles L. Bennett
  • CACara Angelotta
    Cara Angelotta
  • PYPaul R. Yarnold
    Paul R. Yarnold
  • JZJeffrey A. Zonder
    Jeffrey A. Zonder
  • DRDennis W. Raisch
    Dennis W. Raisch
  • PRPaul Richardson
    Paul Richardson

Abstract
To the Editor: The immunomodulatory drugs thalidomide and lenalidomide recently received US Food and Drug Administration approval for the treatment of multiple